1-167021755-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032858.3(MAEL):āc.1205A>Gā(p.Asn402Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_032858.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAEL | NM_032858.3 | c.1205A>G | p.Asn402Ser | missense_variant | 12/12 | ENST00000367872.9 | NP_116247.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAEL | ENST00000367872.9 | c.1205A>G | p.Asn402Ser | missense_variant | 12/12 | 1 | NM_032858.3 | ENSP00000356846 | P1 | |
MAEL | ENST00000367870.6 | c.1112A>G | p.Asn371Ser | missense_variant | 11/11 | 1 | ENSP00000356844 | |||
MAEL | ENST00000622874.4 | c.1037A>G | p.Asn346Ser | missense_variant | 13/13 | 1 | ENSP00000482771 | |||
MAEL | ENST00000491055.5 | n.1896A>G | non_coding_transcript_exon_variant | 12/12 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000757 AC: 19AN: 251012Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135682
GnomAD4 exome AF: 0.0000732 AC: 107AN: 1461194Hom.: 0 Cov.: 30 AF XY: 0.0000812 AC XY: 59AN XY: 726914
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74306
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at